Wednesday , 29 July 2015

Recent Posts

aobiome

AOBiome’s New Ammonia Oxidizing Bacteria-Based Therapeutic Acne Treatment

AOBiome announced that they have already started the Phase 2 trial on a therapeutic creation candidate that was based on a proprietary AOB, or ammonia oxidizing bacteria. It was intended for treatment of mild to average acne vulgaris. This test with B244 is a product candidate under IND application to FDA and the first to try the potential of live ...

Read More »